Molecular Proliferation Marker Ki-67 in Breast Cancer: The Role of Vitamin D Status, Hormone Receptor Expression, and Clinicopathological Factors—A Cross-Sectional Study

Ki-67 is a well-established nuclear biomarker of tumor cell proliferation with key importance for the molecular classification and prognostic stratification of breast cancer. This cross-sectional study included 101 women with histopathologically confirmed invasive breast cancer treated at the St. John of Dukla Oncology Center of the Lublin Region (COZL), Poland (2018–2019). Ki-67 expression was assessed immunohistochemically on formalin-fixed, paraffin-embedded tumor tissue, and independent predictors were identified using multiple linear regression. The median Ki-67 was 20% (IQR: 15–40%). Ki-67 differed significantly between molecular subtypes (Kruskal–Wallis test H = 16.122; p = 0.001; η2 = 0.138): Luminal A tumors had the lowest Ki-67 (median 18%), whereas the Luminal B, HER2-enriched, and Triple-negative subtypes showed higher values (median 30% each). Ki-67 was significantly lower in tumors expressing the estrogen receptor (p = 0.005) and progesterone receptor (p = 0.023). Because the Luminal A/B distinction incorporates a Ki-67 threshold by definition, a multivariable model excluding molecular subtype was fitted using ER, PR, HER2, menopausal status, age, BMI category, and 25(OH)D as candidate predictors. This model identified HER2 positivity (b = 11.26; p = 0.024) and postmenopausal status (b = 17.93; p = 0.017) as independent predictors of higher Ki-67, with a borderline inverse association for age (b = −0.65; p = 0.092); the model explained 10.1% of variance (R2 = 0.101; F(3,95) = 3.574; p = 0.017), and neither ER, PR, BMI, nor 25(OH)D were retained. Serum 25(OH)D concentration showed no meaningful association with Ki-67, either unadjusted (Spearman ρ = 0.035; p = 0.730) or when forced into the retained multivariable model regardless of significance (adjusted b = −0.032; 95% CI: −0.337–0.272; p = 0.834); no association was observed between circulating 25(OH)D and Ki-67 in this cohort, although indirect biological relationships cannot be excluded.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-10-01
DOI
https://doi.org/10.3390/ijms27198797
Primary Topic
Vitamin D Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Molecular Proliferation Marker Ki-67 in Breast Cancer: The Role of Vitamin D Status, Hormone Receptor Expression, and Clinicopathological Factors—A Cross-Sectional Study

Anna Beata Pacian, Monika Baryła‐Matejczuk, Teresa Bernadetta Kulik, Robert Jan Łuczyk et al.
International Journal of Molecular Sciences
Vitamin D Research Studies
article

Molecular Proliferation Marker Ki-67 in Breast Cancer: The Role of Vitamin D Status, Hormone Receptor Expression, and Clinicopathological Factors—A Cross-Sectional Study

Anna Beata Pacian, Monika Baryła‐Matejczuk, Teresa Bernadetta Kulik, Robert Jan Łuczyk, Dorota Weber
article en

Abstract

Ki-67 is a well-established nuclear biomarker of tumor cell proliferation with key importance for the molecular classification and prognostic stratification of breast cancer. This cross-sectional study included 101 women with histopathologically confirmed invasive breast cancer treated at the St. John of Dukla Oncology Center of the Lublin Region (COZL), Poland (2018–2019). Ki-67 expression was assessed immunohistochemically on formalin-fixed, paraffin-embedded tumor tissue, and independent predictors were identified using multiple linear regression. The median Ki-67 was 20% (IQR: 15–40%). Ki-67 differed significantly between molecular subtypes (Kruskal–Wallis test H = 16.122; p = 0.001; η2 = 0.138): Luminal A tumors had the lowest Ki-67 (median 18%), whereas the Luminal B, HER2-enriched, and Triple-negative subtypes showed higher values (median 30% each). Ki-67 was significantly lower in tumors expressing the estrogen receptor (p = 0.005) and progesterone receptor (p = 0.023). Because the Luminal A/B distinction incorporates a Ki-67 threshold by definition, a multivariable model excluding molecular subtype was fitted using ER, PR, HER2, menopausal status, age, BMI category, and 25(OH)D as candidate predictors. This model identified HER2 positivity (b = 11.26; p = 0.024) and postmenopausal status (b = 17.93; p = 0.017) as independent predictors of higher Ki-67, with a borderline inverse association for age (b = −0.65; p = 0.092); the model explained 10.1% of variance (R2 = 0.101; F(3,95) = 3.574; p = 0.017), and neither ER, PR, BMI, nor 25(OH)D were retained. Serum 25(OH)D concentration showed no meaningful association with Ki-67, either unadjusted (Spearman ρ = 0.035; p = 0.730) or when forced into the retained multivariable model regardless of significance (adjusted b = −0.032; 95% CI: −0.337–0.272; p = 0.834); no association was observed between circulating 25(OH)D and Ki-67 in this cohort, although indirect biological relationships cannot be excluded.

International Journal of Molecular SciencesVol. 27(19)
Medical University of Lublin (PL), University of Siedlce (PL), University of Economics and Innovation (PL)
Good health and well-being
Openalex Percentile: Top 12%
Vitamin D Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.